Drugmakers bank on cancer treatments for profit

09/2/2009 | NYTimes.com

Pharmaceutical and biotech companies are investing billions of dollars in cancer drug research as profit from blockbuster drugs wanes and scientists find additional therapeutic targets. However, genetic changes in cells and varying cases of cancer on the molecular level present challenges to drugmakers hoping to grab a share of the lucrative market for next-generation cancer treatments.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC